Drug recalls

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Re…

American Regent, Inc. · Subpotent product in addition to having out-of-specification results for impurities.

Class IITerminatedD-0507-2024
Status
Terminated
City
New Albany
State
OH
Country
United States
Classification
Class II
Product type
Drugs
Event ID
94619
Recalling firm
American Regent, Inc.
Address 1
6610 New Albany Rd E
Postal code
43054-8730
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
USA Nationwide
Recall number
D-0507-2024
Product quantity
2,352 vials
Reason for recall
Subpotent product in addition to having out-of-specification results for impurities.
Recall initiation date
20240513
Center classification date
20240521
Termination date
20251222
Report date
20240529
Code info
Lot #: 23061L1C0, Exp 1/31/2025
Product description

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01

Harmonized identifiers (openFDA)
Application number
NDA212593
Brand name
VASOPRESSIN
Generic name
VASOPRESSIN
Manufacturer name
American Regent, Inc.
Product NDC
0517-1020, 0517-1030
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
VASOPRESSIN
RxCUI
313578, 2103182
SPL ID
36148e09-1c3c-4878-a194-8e10291972ff
SPL set ID
0ab267f4-9ec9-44fd-8521-f975074667d9
Package NDC
0517-1020-01, 0517-1020-25, 0517-1030-01
Is original packager
true
Upc
0305171030017
Nui
M0022562, N0000009908, N0000175360
Pharm class cs
Vasopressins [CS]
Pharm class pe
Vasoconstriction [PE], Decreased Diuresis [PE]
UNII
Y4907O6MFD
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.